Clinical trial Recruiting at 2 sites Interventional Ages 20 to 99

Comparing high flow nasal cannula to facial masks for chest trauma patients

Official title: Noninvasive Ventilation With High Flow Nasal Cannula Compared With Facial Mask in Patients With Chest Trauma: a Randomized Controlled Study

Run by National Taiwan University Hospital · NCT05828030 · Data updated 2026-11-12

This study is testing if high flow nasal cannulas can help chest trauma patients breathe better and avoid needing a breathing tube compared to regular facial masks.

More Hypoxia trials

Quick facts

Study typeInterventional
Ages20 Years to 99 Years
SexAll
Enrollment100 (estimated)
SponsorNational Taiwan University Hospital
Academic / other
Locations2 sites (Taipei, Taipei and 1 other locations)
StatusRecruiting
StartedApril 26, 2023
Main results expectedDecember 31, 2026
Study endsDecember 31, 2027
Registry record updatedSeptember 8, 2025
Trial IDNCT05828030 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients who have experienced chest trauma and exhibit severe hypoxemic respiratory failure within 72 hours of their injury.

Probably not a fit

Patients with severe brain injuries or those who are unable to tolerate non-invasive ventilation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of high flow nasal cannula (HFNC) compared to traditional facial masks in patients suffering from severe hypoxemia due to chest trauma. Conducted across three centers, the study will randomize eligible patients who are experiencing respiratory distress and have low arterial oxygen levels despite receiving standard oxygen therapy. The goal is to determine if HFNC can reduce the need for intubation in these patients within the first 72 hours after their injury.

Why it matters

Potential benefit: If successful, this study could provide a less invasive and more effective treatment option for patients with severe hypoxemia due to chest trauma.

How similar studies have gone: While traditional methods for managing hypoxemia in trauma patients have been established, the use of HFNC in this context is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients who have the following condition within 72 hours of chest trauma despite receiving standard nasal cannula oxygen therapy \[≥10 L/min\], are eligible for inclusion.

* severe hypoxemic respiratory failure \[Arterial partial pressure of oxygen (PaO2)/fraction of inspired oxygen fraction(FiO2) \<300 mmHg\]
* with a respiratory rate \>25 breaths/minute and difficulty breathing, or respiratory distress
* PaCO2 of 45 mmHg or higher (if the patient requires emergency surgery with endotracheal intubation and mechanical ventilation, the time of inclusion will be the start of the post-extubation period. (Note: For patients who receive emergency trauma surgery with endotracheal intubation and mechanical ventilation, the time of inclusion assessment will be 72 hours after extubation.)

Exclusion Criteria:

1. Patients with a Glasgow Coma Scale less than 8 or severe brain injury.
2. Patients with any contraindications to non-invasive ventilation, including acute gastrointestinal bleeding, upper airway obstruction, or hemodynamic instability.
3. Facial trauma involving skull base fractures, facial bone fractures, or orbital floor fractures.
4. Severe injuries involving the nasal sinuses.
5. Patients with cervical spine injuries.
6. Patients with increased intracranial pressure.
7. Patients with facial, nasal, or airway structural abnormalities or surgery that prevents the use of appropriate nasal cannula.
8. Patients after upper airway surgery.
9. Patients who are unable to clearly express their willingness to sign informed consent.

Where it's running

  • Department of Traumatology, National Taiwain University Hospital
    Taipei, Taipei, Taiwan
    Recruiting
  • NTUH Hsin-Chu Branch; NTUH Yun-Lin Branch
    Taipei, Taiwan, Taiwan
    Recruiting

Study contacts

  • Principal investigator: Hsien-Chi Liao, MD — department of trauma of National University Hospital
  • Study coordinator: Hsien-Chi Liao, MD
  • Email: polarisliao@hotmail.com
  • Phone: +886-972651611

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.